63 Results

People

  1. Dupont
    Dupont
  2. Yang
    Yang
  3. Hsu
    Hsu
  4. O'Reilly
    O'Reilly
  5. Cereb
    Cereb
  6. Old
    Old
  7. Gnjatic
    Gnjatic
  8. Ritter
    Ritter
  9. Doubrovina
    Doubrovina
  10. Hasan
    Hasan

Groups

  1. Department of Medicine (26)
  2. GSK Faculty (24)
  3. Tow Center for Developmental Oncology (TCDO) (17)
  4. Center for Hematologic Malignancies (16)
  5. Sloan Kettering Institute Faculty (15)
  6. Hematologic Malignancies Research (14)
  7. Sloan Kettering Institute Postdocs (13)
  8. Human Oncology and Pathogenesis Program (11)
  9. Pediatrics, Department of (11)
  10. Center for Molecular Imaging and Biotechnology (10)
  1. "hla antigen class 1"
Formats
  1. Journal Article (62)
  2. Conference Paper (1)
Groups
  1. Department of Medicine (26)
  2. GSK Faculty (24)
  3. Tow Center for Developmental Oncology (TCDO) (17)
  4. Center for Hematologic Malignancies (16)
  5. Sloan Kettering Institute Faculty (15)
  6. Hematologic Malignancies Research (14)

More Groups

People
  1. Bo Dupont (15)
  2. Soo Yang (10)
  3. Katharine Hsu (8)
  4. Richard O'Reilly (6)
  5. Annamalai Selvakumar (5)
  6. Lloyd Old (5)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (2)
  5. 2021 (3)
  6. 2018 (1)

More Years

Publications
  1. Journal of Immunology (7)
  2. Tissue Antigens (7)
  3. Blood (5)
  4. Clinical Cancer Research (3)
  5. Proceedings of the National Academy of Sciences of the United States of America (3)
  6. Biology of Blood and Marrow Transplantation (2)

More Publications

Publishers
  1. Elsevier Inc. (8)
  2. The American Association of Immunologists, Inc (7)
  3. Wiley-Blackwell Publishing, Inc. (7)
  4. American Association for Cancer Research (6)
  5. American Society of Hematology (5)
  6. Nature Publishing Group (4)

More Publishers

Results (63)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Unique functional status of natural killer cells in metastatic stage IV melanoma patients and its modulation by chemotherapy
    Journal Article

    Fregni, G.; Perier, A.; Pittari, G.; Jacobelli, S.; Sastre, X.; Gervois, N.; Allard, M.; Bercovici, N.; Avril, M. F.; Caignard, A.
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Long-term remission after CD34+ -selected PBSCT in a patient with advanced intra-abdominal desmoplastic small round-cell tumor
    Journal Article

    Houet, L.; Moller, I.; Engelhardt, M.; Köhler, G.; Schmidt, H.; Herchenbach, D.; Schnitzler, M.; Schmitt-Graeff, A.; Jungbluth, A. A.; Mertelsmann, R.; more...
    Bone Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma
    Journal Article

    Venstrom, J. M.; Zheng, J.; Noor, N.; Danis, K. E.; Yeh, A. W.; Cheung, I. Y.; Dupont, B.; O'Reilly, R. J.; Cheung, N. K. V.; Hsu, K. C.
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • Early hematopoietic zinc finger protein prevents tumor cell recognition by natural killer cells
    Journal Article

    La Rocca, R.; Fulciniti, M.; Lakshmikanth, T.; Mesuraca, M.; Ali, T. H.; Mazzei, V.; Amodio, N.; Catalano, L.; Rotoli, B.; Ouerfelli, O.; more...
    Journal of Immunology (2009)

    Fulltext@MSK | Save
  • A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy
    Journal Article

    Hasan, A. N.; Kollen, W. J.; Trivedi, D.; Selvakumar, A.; Dupont, B.; Sadelain, M.; O'Reilly, R. J.
    Journal of Immunology (2009)

    Fulltext@MSK | Save
  • Identification of a human cyclin D1-derived peptide that induces human cytotoxic CD4 T cells
    Journal Article

    Dao, T.; Korontsvit, T.; Zakhaleva, V.; Haro, K.; Packin, J.; Scheinberg, D. A.
    PLoS ONE (2009)

    Fulltext@MSK | Save
  • HLA class i-associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine
    Journal Article

    Bioley, G.; Guillaume, P.; Luescher, I.; Yeh, A.; Dupont, B.; Bhardwaj, N.; Mears, G.; Old, L. J.; Valmori, D.; Ayyoub, M.
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • Recognition of naturally processed and ovarian cancer reactive CD8 + T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1
    Journal Article

    Matsuzaki, J.; Qian, F.; Luescher, I.; Lele, S.; Ritter, G.; Shrikant, P. A.; Gnjatic, S.; Old, L. J.; Odunsi, K.
    Cancer Immunology, Immunotherapy (2008)

    Fulltext@MSK | Save
  • Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer
    Journal Article

    Odunsi, K.; Qian, F.; Matsuzaki, J.; Mhawech-Fauceglia, P.; Andrews, C.; Hoffman, E. W.; Pan, L.; Ritter, G.; Villella, J.; Thomas, B.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2007)

    Fulltext@MSK | Save
  • KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro
    Journal Article

    Chewning, J. H.; Gudme, C. N.; Hsu, K. C.; Selvakumar, A.; Dupont, B.
    Journal of Immunology (2007)

    Fulltext@MSK | Save